One study showed that depleting CD8+ T cells by using a CD8α blocking antibody alleviates infarct volume and behavioral deficits in both transient middle cerebral artery occlusion (tMCAO) and permanent MCAO ischemia model mice. The gene discussed is CD8A; the disease is ischemia.